(Q46973837)

English

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial

scientific article published in November 2005

In more languages
default for all languages
No label defined

No description defined

Statements

[Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial]. (English)
Cosmic COPD and Serentide: A Multi-Center Intervention and Characterization Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit